Denmark · Delayed Price · Currency is DKK Pharma Equity Group Statistics
Total Valuation
CPH:PEG has a market cap or net worth of DKK 95.26 million. The enterprise value is 105.97 million.
| Market Cap | 95.26M |
| Enterprise Value | 105.97M |
Important Dates
The next estimated earnings date is Monday, November 16, 2026.
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CPH:PEG has 1.23 billion shares outstanding. The number of shares has increased by 4.86% in one year.
| Current Share Class | 1.23B |
| Shares Outstanding | 1.23B |
| Shares Change (YoY) | +4.86% |
| Shares Change (QoQ) | -14.29% |
| Owned by Insiders (%) | 4.70% |
| Owned by Institutions (%) | n/a |
| Float | 742.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.69 |
| P/TBV Ratio | 3.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.09, with a Debt / Equity ratio of 0.42.
| Current Ratio | 3.09 |
| Quick Ratio | 0.23 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.02 |
| Interest Coverage | -3.22 |
Financial Efficiency
Return on equity (ROE) is -32.07% and return on invested capital (ROIC) is -13.10%.
| Return on Equity (ROE) | -32.07% |
| Return on Assets (ROA) | -11.61% |
| Return on Invested Capital (ROIC) | -13.10% |
| Return on Capital Employed (ROCE) | -32.73% |
| Weighted Average Cost of Capital (WACC) | 11.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.09M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.06M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.65% in the last 52 weeks. The beta is 1.01, so CPH:PEG's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -36.65% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.09 |
| Relative Strength Index (RSI) | 44.66 |
| Average Volume (20 Days) | 285,269 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.89M |
| Pretax Income | -11.51M |
| Net Income | -10.45M |
| EBITDA | -9.88M |
| EBIT | -9.89M |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 29,000 in cash and 10.75 million in debt, with a net cash position of -10.72 million or -0.01 per share.
| Cash & Cash Equivalents | 29,000 |
| Total Debt | 10.75M |
| Net Cash | -10.72M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 25.79M |
| Book Value Per Share | 0.02 |
| Working Capital | 29.15M |
Cash Flow
| Operating Cash Flow | -10.52M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 7,000 |
| Net Borrowing | 3.57M |
| Free Cash Flow | -10.52M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CPH:PEG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.86% |
| Shareholder Yield | -4.86% |
| Earnings Yield | -10.97% |
| FCF Yield | -11.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |